What are the future trends of medical devices? In the rapidly evolving landscape of healthcare, staying informed about the latest advancements in medical technology is essential for professionals and ...
“We developed LithiX to improve the IVL treatment of calcified lesions with shorter procedure times and effectiveness across a broad range of calcified lesions, and we’re delighted with the PINNACLE I ...
Cytomos, an Edinburgh-based biotechnology company, has raised £5 million to scale up production of its unique cell analysis technology. The oversubscribed funding round was led by existing investors ...
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health ...
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today ...
TactoTek, the global leader in In-Mold Structural Electronics (IMSE ®) technology, today announced the completion of a $60 million funding round led by Nidoco AB, part of Virala Group. The financing ...
Patient engagement platforms are changing how healthcare is delivered by improving communication and handling administrative tasks. These platforms can send appointment reminders, procedure ...
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks ...
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology company focused on the development and commercialization of ...
to help improve the standard of care in hospitals for sponge management and blood loss assessment Stryker (NYSE:SYK), a global leader in medical technologies, announced its launch of the next ...
Secured financing advances Instylla's clinical trials and commercialization readiness Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular ...